Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

B7-DC Xab Plasma Therapy for the Treatment of Metastatic Melanoma. A Feasibility/Pilot Study

NCT00658892 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00658892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00658892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
B7-DC Xab Plasma Therapy for the Treatment of Metastatic Melanoma. A Feasibility/Pilot Study
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
April 8, 2008
Completion date
May 22, 2012
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)